Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KEYS vs GSK✓SelectedUSD · GSKKEYS vs GSK performance historyLatest closeAs of-4.05%11/16
Stock and ETF performance explorer

KEYS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-16.1%
GSK return
+3.1%
Excess return
-19.2%
Maximum drawdown
-32.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-4.0%-4.1%
7D-1.2%-1.3%+0.2%-1.9%
30D-13.8%+2.7%-16.5%-11.5%
3M-20.2%+2.7%-22.9%-17.2%
All-16.1%+3.1%-19.2%-14.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling